Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitleLetter: Experience of switching vedolizumab treatment from intravenous to subcutaneous formulation in Hungary.AuthorsBacsur, Péter; Iliás, Ákos; Resál, Tamás; Kata, Diána; Molnár, Tamás; Farkas, KlaudiaAbstractLINKED CONTENT: This article is linked to Volkers et al paper. To view this article, visit https://doi.org/10.1111/apt.17153SubjectsHUNGARY; VEDOLIZUMABPublicationAlimentary Pharmacology & Therapeutics, 2023, Vol 58, Issue 2, p262ISSN0269-2813Publication typeArticleDOI10.1111/apt.17610